Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Apr 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5036682013 | Magnesium hydroxide 750 microlitre/mL and mineral oil 250 microlitre/mL oral suspension | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 5036683015 | Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 5036684014 | Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral suspension | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug) | Is a | Product containing only magnesium hydroxide and mineral oil in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug) | Has manufactured dose form | Conventional release oral suspension | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug) | Plays role | Stool softener therapeutic role | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug) | Plays role | Laxative therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Mineral oil | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance | Mineral oil | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | Microliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Magnesium hydroxide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance | Magnesium hydroxide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | Microliter | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR